Market
leading Products
|
The remarkable biostability of Elast-Eon™ materials makes them ideally suited for use in a vast range of common medical devices, where silicon or silicon gel can no longer be used due to the possibility of implant deterioration or adverse allergic reactions. |
 |
Though Elast-Eon™ is created by combining both polyurethane elastomers and silicon gel, the resultant copolymers are robust, biologically stable and compatible with the human body. This presents manufacturers with exiting new product development prospects that could revolutionize the medical device market.
Elast-Eon™ products
are now available in a wide variety of formulations, ranging from very
flexible to rigid. What's more the density and mechanical properties of
these materials can be further refined to meet the precise requirements
of clinicians and medical device designers.
 |
|
(Click
on a image to enlarge)
|
The first generation of Elast-Eon™ products were developed for critical, life supporting applications in the fields of cardiovascular surgery, interventional cardiology, cardiac rhythm management and drug delivery.
|
|
Discussions are also
being held with other potential licensees in those sectors where non-exclusive
licences are currently held. |
These new materials are suitable for applications in a wide a range of therapy areas including orthopaedic and plastic surgery.
A grade of Elast-Eon™ has also been developed with the specific intent of addressing the strength and safety concerns that exist with the current breast implant products. Feasibility and prototype device phases are complete and the company is actively seeking a corporate partner.
With such a range of lucrative applications the future for Elast-Eon™ technology and AorTech as a company seems bright.
|
|